A Digital Health Parent-Training Intervention for Children With Social Communication Delays
Part of paid clinical trials in Miami, Florida.
- Sponsor
- Florida International University
- Study ID
- NCT07551752
- Status
- Recruiting
Conditions
- Autism Spectrum Disorder
- Social Communication Delay
Eligibility Criteria
- Sex
- ALL
- Age
- 14 Months - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Online Parent Training in Early Behavioral Intervention (OPT-In-Early) — BEHAVIORALOPT-In-Early is an online 14-module self-directed naturalistic developmental behavioral intervention (NDBI) that uses simple text, narration, and interspersed videos to teach parents how to increase their children's social engagement, communication, adaptive behaviors, and reduce challenging behaviors.
Study Details
Early intervention, during a time of optimal brain plasticity, is critical for autistic children to develop functional skills such as communication and daily living abilities. However, many families face barriers to accessing timely autism-specific services due to delays in autism diagnosis (which is often a prerequisite to autism-specific intervention), long waitlists, high costs, and the necessity to travel far distances to service providers. Self-directed parent-mediated digital health interventions (i.e., programs that parents complete online without provider coaching or feedback) offer a scalable solution to reduce challenges accessing intervention by providing evidence-based strategies that parents can implement without relying on traditional service pathways. The proposed pilot randomized controlled trial (RCT) will test a revised self-directed parent-training program, that teaches parents naturalistic developmental behavioral intervention (NDBI) strategies, which have proven effective for young children with autism. The study will include young children who have already been diagnosed with autism and those who screen positive on an autism screener but have not yet been evaluated, enabling earlier intervention before a formal diagnosis. The study will also explore parents' willingness to engage in the intervention. The specific research aims are: (1) test the preliminary efficacy of the parent-training program vs. treatment as usual (TAU) for 50 children with autism traits and their parents; (2) examine parent engagement in the intervention; and (3) explore predictors of engagement.
Key Dates
- Start date
- Apr 11, 2026
- Status verified
- Apr 2026
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- No Intervention: Treatment as Usual (TAU)This arm will complete treatment as usual during the 4 months of the study. Specifically, if the family is receiving any intervention, they will continue to receive it. Once the post-treatment study visit is completed, they will be granted access to the intervention being studied (OPT-In-Early)
- Experimental: Treatment (OPT-In-Early) groupThe intervention group will receive access to OPT-In-Early. OPT-In-Early is an online 14-module self-directed parent-training program that uses simple text, narration, and interspersed videos to teach parents how to increase their children's social engagement, communication, adaptive behaviors, and reduce challenging behaviors.
Primary Outcome Measure
Motor Imitation Scale [ Time Frame: Baseline and 4 months ]
Central Contacts
- Yael Dai Dr. Yael Dai, PhD305-348-1034
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Florida International University | Miami | Florida | 33199 | Dr. Yael Dai, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Miami, FL
Related Studies
- International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum DisorderRecruiting · Stalicla SA · Phoenix, Arizona
- ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)PHASE2 · Enrolling By Invitation · MapLight Therapeutics · Dothan, Alabama
- Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderPHASE3 · Recruiting · Intra-Cellular Therapies, Inc. · Phoenix, Arizona
- Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum DisorderPHASE1 · Recruiting · Intra-Cellular Therapies, Inc. · Miami, Florida